Regardless of race, when compared to women with luminal A‐like breast tumors, patients with TNBC and luminal B/HER2‐ breast tumors (both P < 0.0001) had over a two‐fold higher risk of death. The gene discussed is ERBB2; the disease is breast neoplasm.